Publication date: January 2027 Source: Molecular Metabolism, Volume 115 Author(s): Stephanie A. Mowery, Patrick J. Knerr, Karina Rahr Hjøllund, Birgitte Nissen, Anette K. Olsen, Trine Levring Wilkens, Lasse Hjort Kyneb Jakobsen, Christian Hollesen, Kateryna Breusova, Joyce Sorrell, Diego Perez-Tilve, Brian Finan, Richard D. DiMarchi, Charlotta Dornonville de la Cour
Discovery, optimization, and phase 1 evaluation of a novel, orally available GLP-1R/GIPR dual agonist. // Molecular Metabolism. – URL: https://www.sciencedirect.com/science/article/pii/S2212877826001547?dgcid=rss_sd_all
Discovery, optimization, and phase 1 evaluation of a novel, orally available GLP-1R/GIPR dual agonist. Molecular Metabolism. https://www.sciencedirect.com/science/article/pii/S2212877826001547?dgcid=rss_sd_all
“Discovery, optimization, and phase 1 evaluation of a novel, orally available GLP-1R/GIPR dual agonist.” Molecular Metabolism.
@article{article58901,
title = {Discovery, optimization, and phase 1 evaluation of a novel, orally available GLP-1R/GIPR dual agonist},
journal = {Molecular Metabolism},
url = {https://www.sciencedirect.com/science/article/pii/S2212877826001547?dgcid=rss_sd_all}
}
Gene Therapy, Published online: 13 November 2026; doi:10.1038/s41434-026-00658-6 Clinical landscape of gene therapy for rare diseases: a registry-based analysis of clinical trials and FDA-approved products
Human Genome Variation, Published online: 12 November 2026; doi:10.1038/s41439-026-00361-3 Arthrogryposis involves multiple joint contractures present at birth, affecting both upper and lower extremities. This study investigates the...
Gene Therapy, Published online: 10 November 2026; doi:10.1038/s41434-026-00657-7 Perspectives on cell and gene therapy: insights from the 5th China Annual Congress on CGT
Gene Therapy, Published online: 04 November 2026; doi:10.1038/s41434-026-00649-7 High-resolution separation and quantification of dual-AAV drug products by density gradient equilibrium analytical ultracentrifugation
Gene Therapy, Published online: 03 November 2026; doi:10.1038/s41434-026-00656-8 Genotoxic safety and long-term engraftment dynamics of efficient translational CRISPR/Cas9 therapeutics for β-haemoglobinopathies from bench to clinical trials